arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Travere Therapeutics, Inc.

TVTX

$61.33 ▼ -1.12 (-1.79%) at close

16 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Travere Therapeutics, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $5.5B

Dividend Yield —

Revenue Growth 110.5% ↗

Op. Margin -12.8% ↗

ROIC -55.8% ↗

FCF / Share $0.42 ↗

Trailing P/E —

Price / Book 48.6x

FCF Yield 0.7%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$490.73M

↑ +110.5% —

Net Income Profit after all expenses

$-25.55M

↑ +92.1% —

Operating Margin Operating profit as % of sales

-12.8%

↑ +90.8% 13th

FCF / Share Free cash flow per share

$0.42

↑ +114.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↑

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Feb 28, 2011 10-K ↗
Revenue Growth YoY (%)	110.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1281%)	60.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+657%)	32.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+309%)	-51.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-749%)	14.7% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+84%)	13.1% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+64%)	6.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-16%)	6.0% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-25%)	16.0% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+100%)	33.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+322%)	254.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3077%)	—	—	—	—	—
EPS Growth YoY (%)	92.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-172.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	65.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-45.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	15.4% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	-64.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-19.4% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—
Net Income Growth YoY (%)	92.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-188.6% Weak ↓ Weak Declining Year-over-year change in net income	60.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-54.6% Weak ↓ Weak Declining Year-over-year change in net income	-6.3% Weak ↑ Weak Improving Year-over-year change in net income	-15.7% Weak ↑ Weak Improving Year-over-year change in net income	-42.6% Weak ↑ Weak Improving Year-over-year change in net income	-71.9% Weak Weak Year-over-year change in net income	-24.7% Weak Weak Year-over-year change in net income	N/M	N/M	-64.5% Weak Weak Year-over-year change in net income	-122.2% Weak Weak Year-over-year change in net income	—	—	—
FCF Growth YoY (%)	N/M	20.4% Good ↑ Good Improving Year-over-year change in free cash flow	-29.2% Weak ↑ Weak Improving Year-over-year change in free cash flow	-779.7% Weak Weak Year-over-year change in free cash flow	68.1% Excellent Excellent Year-over-year change in free cash flow	—	—	N/M	N/M	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	64.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	0.8% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-9.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-14.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	11.5% Good → Good Stable Compound annual revenue growth over 3 years	8.6% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	9.5% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	18.0% Excellent Excellent Compound annual revenue growth over 3 years	76.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	19.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	5.9% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-2.4% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-6.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	11.2% Good ↓ Good Declining Compound annual revenue growth over 5 years	14.7% Excellent Excellent Compound annual revenue growth over 5 years	44.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Feb 28, 2011 10-K ↗
Operating Margin (%) (%)	-12.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-185%)	-138.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1026%)	-267.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1882%)	-292.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2048%)	-71.1% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-574%)	-88.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-692%)	-78.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-622%)	-48.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-425%)	-34.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-331%)	-43.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-391%)	-50.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-439%)	-283.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1987%)	—	—	—	—
Effective Tax Rate (%) (%)	-2.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	10.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	16.8% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-11.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	-5.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-143%)	-137.9% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1249%)	-76.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-739%)	-254.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2220%)	-79.2% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-760%)	-85.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-812%)	-83.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-796%)	-62.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-621%)	-38.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-421%)	-35.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-399%)	—	-393.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3378%)	—	—	—	—
FCF Margin (%) (%)	7.7% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	-101.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-193.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-170.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-8.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-25.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-33.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-15.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	4.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-3.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—
FCF / Net Income (x)	-1.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.52x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.11x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.25x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.11x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.32x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.09x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	0.03x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Feb 28, 2011 10-K ↗
Return on Invested Capital (%)	-55.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-548.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-193.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-747.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-53.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-74.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	209.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	314.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	701.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-47.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-29.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-280.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1265.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-22.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-248%)	—	-55.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-470%)	—	-59.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-497%)	-80.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-635%)	-66.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-541%)	-32.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-315%)	-20.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-15.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-204%)	39.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+161%)	297.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1885%)	—	—	—	38.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+155%)

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Feb 28, 2011 10-K ↗
Interest Coverage (x)	-7.11x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-36.64x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-34.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-29.07x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8.05x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-9.22x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-7.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-72.77x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.78x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-441.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	-359.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-93.03M	$-58.53M	$-58.18M	$-61.69M	$-165.75M	$-84.77M	$-62.44M	$-102.87M	$-99.39M	$-41.00M	$-37.80M	$-18.20M	$-6.00M	$-11.39K	$-10.05K	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Feb 28, 2011 10-K ↗
Revenue per Share (USD)	$5.50	$2.96	$1.96	$1.72	$3.80	$4.17	—	$4.06	$4.00	$3.61	$2.98	$1.13	—	—	—	—
Basic EPS, GAAP (USD)	$-0.29	$-4.08	$-1.50	$-4.37	$-3.01	$-3.56	—	$-2.54	$-1.54	$-1.29	$3.49	$-4.43	—	—	—	—
Free Cash Flow per Share (USD)	$0.42	$-3.01	$-3.78	$-2.92	$-0.33	$-1.04	—	$-0.64	$0.17	$-0.13	—	—	—	—	—	—
Book Value per Share (USD)	$1.26	$0.68	$2.66	$0.67	$4.83	$4.04	$5.13	$7.69	$7.44	$8.12	$8.23	$-1.43	$-0.99	$-0.38	$-0.13	—
Tangible Book Value per Share (USD)	$0.01	$-0.52	$1.27	$-0.86	$2.44	$1.08	$1.46	$3.16	$2.73	$3.29	$3.77	$-1.47	$-0.99	$-0.38	$-0.13	—
Basic Weighted Avg Shares (shares)	89.21M	78.89M	74.27M	63.76M	59.83M	47.54M	—	40.43M	38.77M	37.00M	33.56M	25.06M	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Feb 28, 2011 10-K ↗
Working Capital (USD)	$277.66M	$215.95M	$438.87M	$344.27M	$458.74M	$317.75M	$333.62M	$391.06M	$240.14M	$249.09M	$214.95M	$-70.20M	$-27.71M	$-5.77M	$-538.80K	—
Total Equity (USD)	$114.83M	$59.08M	$200.81M	$42.85M	$302.11M	$211.21M	$221.20M	$318.25M	$293.13M	$307.77M	$299.97M	$-37.25M	$-18.31M	$-3.41M	$-536.28K	$-60.26K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Feb 28, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$490.73M	$233.18M	$145.24M	$109.46M	$227.49M	$198.32M	$175.34M	$164.25M	$154.94M	$133.59M	$99.89M	$28.20M	—	—	—	$0.00
Depreciation Expense (USD)	$60.74M	$43.55M	$38.53M	$20.72M	$26.62M	$24.58M	$20.41M	$18.67M	$17.80M	$16.14M	$13.39M	$5.40M	$341.23K	$124.89K	—	—
Net Income, GAAP (USD)	$-25.55M	$-321.55M	$-111.40M	$-278.48M	$-180.09M	$-169.43M	$-146.43M	$-102.68M	$-59.73M	$-47.90M	$117.24M	$-110.94M	$-67.44M	$-30.34M	—	$-23.02K
Operating Cash Flow (USD)	$37.78M	$-237.47M	$-280.02M	$-186.29M	$-14.79M	$-42.74M	$-58.21M	$-24.96M	$7.40M	$-3.44M	—	—	$-21.11M	$-2.74M	—	$-689.00

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 63 quarters

Travere Therapeutics, Inc.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TVTX with peers